The prevalence of SATB2 positivity was lower in Crohn’s disease-associated SBAs (12%) in comparison with both celiac disease-associated (25%) or sporadic (24%) cases; however, the difference in the distribution of SATB2 expression amongst etiologic groups was not significant (p = 0.333). The gene discussed is SATB2; the disease is Crohn disease.